Market capitalization | $61.74m |
Enterprise Value | $72.74m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 1.50 |
P/S ratio (TTM) P/S ratio | 1.27 |
P/B ratio (TTM) P/B ratio | 5.15 |
Revenue growth (TTM) Revenue growth | -3.49% |
Revenue (TTM) Revenue | $48.54m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
4 Analysts have issued a Apyx Medical Corporation forecast:
4 Analysts have issued a Apyx Medical Corporation forecast:
Sep '24 |
+/-
%
|
||
Revenue | 49 49 |
3%
3%
|
|
Gross Profit | 12 12 |
15%
15%
|
|
EBITDA | -21 -21 |
8%
8%
|
EBIT (Operating Income) EBIT | -22 -22 |
7%
7%
|
Net Profit | -28 -28 |
88%
88%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Head office | United States |
CEO | Charles Goodwin |
Employees | 252 |
Founded | 1978 |
Website | apyxmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.